State of Nevada Adopts Official Disability Guidelines Drug Formulary
Las Vegas, NV – The State of Nevada has
officially adopted the Official Disability Guidelines (ODG) Drug
Formulary to support evidence-based care in the workers’ compensation
system, as mandated by Senate Bill 317 (SB317). Nevada is the 13th
state to implement an ODG tool for managing workers’ compensation claims.
Passed during the 2025 Legislative session, SB317
requires the Nevada Division of Industrial Relations (DIR) to adopt
the ODG Drug Formulary. To allow time for training and phased implementation,
DIR is formally adopting the formulary effective September 9, 2025, with a
full implementation date of July 1, 2027.
The ODG Drug Formulary improves healthcare quality and
efficiency by standardizing evidence-based prescribing practices. It promotes
consistency among physicians, enhances patient outcomes, and helps insurers
reduce costs by encouraging the use of effective, lower-cost medications. It
also simplifies the approval process for providers, allowing them to focus more
on patient care.
“The adoption of the ODG Drug Formulary is a major
step forward in making Nevada’s workers’ compensation system more efficient and
patient-centered,” said Victoria Carreón, Administrator of the
Division of Industrial Relations. “By aligning treatment with
evidence-based guidelines, we can reduce delays, improve outcomes, and ensure
injured workers receive the right care at the right time.”
The basic formulary is available free of charge
at: https://www.odgbymcg.com/state-formulary.
Once fully implemented, it will apply to all non-emergency,
outpatient services, with exceptions allowing insurers to approve
non-formulary drugs. Denied requests may be appealed through the Nevada
Hearings Division.